• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大数据与数据再利用——利用现有数据解答血管性痴呆研究中的新问题。

Big data and data repurposing - using existing data to answer new questions in vascular dementia research.

作者信息

Doubal Fergus N, Ali Myzoon, Batty G David, Charidimou Andreas, Eriksdotter Maria, Hofmann-Apitius Martin, Kim Yun-Hee, Levine Deborah A, Mead Gillian, Mucke Hermann A M, Ritchie Craig W, Roberts Charlotte J, Russ Tom C, Stewart Robert, Whiteley William, Quinn Terence J

机构信息

Stroke Association Garfield Weston Foundation Clinical Senior Lecturer, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

VISTA and VICCTA Coordinator, Institutes of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

出版信息

BMC Neurol. 2017 Apr 17;17(1):72. doi: 10.1186/s12883-017-0841-2.

DOI:10.1186/s12883-017-0841-2
PMID:28412946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5392951/
Abstract

INTRODUCTION

Traditional approaches to clinical research have, as yet, failed to provide effective treatments for vascular dementia (VaD). Novel approaches to collation and synthesis of data may allow for time and cost efficient hypothesis generating and testing. These approaches may have particular utility in helping us understand and treat a complex condition such as VaD.

METHODS

We present an overview of new uses for existing data to progress VaD research. The overview is the result of consultation with various stakeholders, focused literature review and learning from the group's experience of successful approaches to data repurposing. In particular, we benefitted from the expert discussion and input of delegates at the 9 International Congress on Vascular Dementia (Ljubljana, 16-18 October 2015).

RESULTS

We agreed on key areas that could be of relevance to VaD research: systematic review of existing studies; individual patient level analyses of existing trials and cohorts and linking electronic health record data to other datasets. We illustrated each theme with a case-study of an existing project that has utilised this approach.

CONCLUSIONS

There are many opportunities for the VaD research community to make better use of existing data. The volume of potentially available data is increasing and the opportunities for using these resources to progress the VaD research agenda are exciting. Of course, these approaches come with inherent limitations and biases, as bigger datasets are not necessarily better datasets and maintaining rigour and critical analysis will be key to optimising data use.

摘要

引言

传统的临床研究方法至今未能为血管性痴呆(VaD)提供有效的治疗方法。新的数据整理和综合方法可能有助于高效地提出和检验假设,且节省时间和成本。这些方法在帮助我们理解和治疗像VaD这样的复杂病症方面可能具有特殊用途。

方法

我们概述了利用现有数据推进VaD研究的新用途。该概述是与各利益相关者协商、重点文献综述以及借鉴该团队数据重新利用成功方法的经验的结果。特别是,我们受益于第九届国际血管性痴呆大会(2015年10月16 - 18日,卢布尔雅那)代表们的专家讨论和意见。

结果

我们确定了可能与VaD研究相关的关键领域:对现有研究进行系统综述;对现有试验和队列进行个体患者层面的分析,以及将电子健康记录数据与其他数据集相链接。我们用一个利用了这种方法的现有项目的案例研究对每个主题进行了说明。

结论

VaD研究群体有很多机会更好地利用现有数据。潜在可用数据的数量在不断增加,利用这些资源推进VaD研究议程的机会令人兴奋。当然,这些方法存在固有的局限性和偏差,因为更大的数据集不一定就是更好的数据集,保持严谨性和批判性分析将是优化数据使用的关键。

相似文献

1
Big data and data repurposing - using existing data to answer new questions in vascular dementia research.大数据与数据再利用——利用现有数据解答血管性痴呆研究中的新问题。
BMC Neurol. 2017 Apr 17;17(1):72. doi: 10.1186/s12883-017-0841-2.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Traditional Chinese herbal medicine for vascular dementia.用于治疗血管性痴呆的传统中草药。
Cochrane Database Syst Rev. 2018 Dec 6;12(12):CD010284. doi: 10.1002/14651858.CD010284.pub2.
5
The project data sphere initiative: accelerating cancer research by sharing data.项目数据领域计划:通过数据共享加速癌症研究
Oncologist. 2015 May;20(5):464-e20. doi: 10.1634/theoncologist.2014-0431. Epub 2015 Apr 15.
6
Facts, myths, and controversies in vascular dementia.血管性痴呆中的事实、误解与争议
J Neurol Sci. 2004 Nov 15;226(1-2):49-52. doi: 10.1016/j.jns.2004.09.011.
7
Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia.基于 iTRAQ 的定量临床蛋白质组学方法揭示血管性痴呆的新病理生理标志物。
J Proteomics. 2014 Mar 17;99(100):54-67. doi: 10.1016/j.jprot.2014.01.011. Epub 2014 Jan 19.
8
Neuroprotection in vascular dementia.血管性痴呆中的神经保护作用
Cerebrovasc Dis. 2006;21 Suppl 2:106-17. doi: 10.1159/000091710. Epub 2006 May 2.
9
Qualitative Study定性研究
10
Statins and vascular dementia: a review.他汀类药物与血管性痴呆:综述
J Alzheimers Dis. 2014;42 Suppl 3:S315-20. doi: 10.3233/JAD-132366.

引用本文的文献

1
The evolution of Big Data in neuroscience and neurology.神经科学与神经病学中大数据的发展
J Big Data. 2023;10(1):116. doi: 10.1186/s40537-023-00751-2. Epub 2023 Jul 10.
2
The benefits of data sharing and ensuring open sources of systematic review data.数据共享和确保系统评价数据开源的好处。
J Public Health (Oxf). 2022 Dec 1;44(4):e582-e587. doi: 10.1093/pubmed/fdac031.
3
Working life, health and well-being of parents: a joint effort to uncover hidden treasures in European birth cohorts.父母的工作生活、健康和幸福:共同努力揭示欧洲出生队列中的隐藏宝藏。
Scand J Work Environ Health. 2021 Oct 1;47(7):550-560. doi: 10.5271/sjweh.3980. Epub 2021 Aug 25.
4
Protocol for the development of a repository of individual participant data from randomised controlled trials conducted in adult care homes (the Virtual International Care Homes Trials Archive (VICHTA)).成人护理院开展的随机对照试验个体参与者数据存储库开发方案(虚拟国际护理院试验档案(VICHTA))。
Trials. 2021 Feb 23;22(1):157. doi: 10.1186/s13063-021-05107-w.
5
Pattern Recognition to Objectively Differentiate the Etiology of Cognitive Decline: Analysis of the Impact of Stroke and Alzheimer's Disease.模式识别客观区分认知衰退的病因:分析中风和阿尔茨海默病的影响。
Neuroepidemiology. 2020;54(6):446-453. doi: 10.1159/000510133. Epub 2020 Oct 5.
6
Application of Big Data and Artificial Intelligence technologies to dementia prevention research: an opportunity for low-and-middle-income countries.大数据和人工智能技术在痴呆症预防研究中的应用:中低收入国家的机遇
J Glob Health. 2019 Dec;9(2):020322. doi: 10.7189/jogh.09.020322.
7
UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedings.英国关于临床前血管性认知障碍功能结局评估的共识:问卷和研讨会记录。
J Cereb Blood Flow Metab. 2020 Jul;40(7):1402-1414. doi: 10.1177/0271678X20910552. Epub 2020 Mar 9.
8
Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia.苯磺酸左旋氨氯地平片治疗血管性痴呆的效果。
Sci Rep. 2019 Dec 3;9(1):18248. doi: 10.1038/s41598-019-47868-0.
9
Pattern Recognition to Identify Stroke in the Cognitive Profile: Secondary Analyses of a Prospective Cohort Study.通过模式识别在认知概况中识别中风:一项前瞻性队列研究的二次分析
Cerebrovasc Dis Extra. 2019;9(3):114-122. doi: 10.1159/000503002. Epub 2019 Oct 8.
10
Fluoxetine in stroke (FOCUS) trial-reasons to be cheerful about antidepressants in stroke?卒中患者使用氟西汀(FOCUS)试验——对卒中患者使用抗抑郁药感到乐观的理由?
Ann Transl Med. 2019 Jul;7(Suppl 3):S131. doi: 10.21037/atm.2019.05.85.

本文引用的文献

1
Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack.脑卒中和短暂性脑缺血发作后血管周围间隙扩大与认知障碍。
Int J Stroke. 2018 Jan;13(1):47-56. doi: 10.1177/1747493016666091. Epub 2016 Aug 19.
2
METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research.用于研究血管疾病及其对认知衰退和神经退行性变影响的元队列研究:神经退行性疾病研究联合项目倡议
Alzheimers Dement. 2016 Dec;12(12):1235-1249. doi: 10.1016/j.jalz.2016.06.004. Epub 2016 Aug 1.
3
Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource.南伦敦和莫兹利国民保健服务基金会信托生物医学研究中心(SLaM BRC)病例登记册的队列概况:源自电子心理健康记录的数据资源的现状及近期改进
BMJ Open. 2016 Mar 1;6(3):e008721. doi: 10.1136/bmjopen-2015-008721.
4
Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.利用临床疾病特征与药物效应之间的互补性推断新药适应症。
J Biomed Inform. 2016 Feb;59:248-57. doi: 10.1016/j.jbi.2015.12.003. Epub 2015 Dec 17.
5
Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method.精神分裂症的阴性症状:一项针对大量临床患者样本采用新型自动化方法的研究。
BMJ Open. 2015 Sep 7;5(9):e007619. doi: 10.1136/bmjopen-2015-007619.
6
The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials.研究氟西汀对近期中风患者影响的FOCUS、AFFINITY和EFFECTS试验:三项多中心随机对照试验的研究方案
Trials. 2015 Aug 20;16:369. doi: 10.1186/s13063-015-0864-1.
7
Trajectory of Cognitive Decline After Incident Stroke.首次中风后认知功能衰退轨迹
JAMA. 2015 Jul 7;314(1):41-51. doi: 10.1001/jama.2015.6968.
8
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.患者脑脊液中的 tau 和淀粉样蛋白-β1-42。
Brain. 2015 Sep;138(Pt 9):2716-31. doi: 10.1093/brain/awv181. Epub 2015 Jun 30.
9
Why strategy matters now.为何战略现在至关重要。
N Engl J Med. 2015 Apr 30;372(18):1681-4. doi: 10.1056/NEJMp1502419.
10
Comparing a knowledge-driven approach to a supervised machine learning approach in large-scale extraction of drug-side effect relationships from free-text biomedical literature.在从自由文本生物医学文献中大规模提取药物-副作用关系方面,将知识驱动方法与监督式机器学习方法进行比较。
BMC Bioinformatics. 2015;16 Suppl 5(Suppl 5):S6. doi: 10.1186/1471-2105-16-S5-S6. Epub 2015 Mar 18.